The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans. Fantini J, Devaux CA, Yahi N, Frutos R, et al. J Infect 2022 Mar 6. pii: S0163-4453(22)00129.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fantini J, Devaux CA, Yahi N, Frutos R, et al. The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans. J Infect 2022 Mar 6. pii: S0163-4453(22)00129.
PMID: 35263637